The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Menarini Silicon Biosystems sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Menarini Silicon Biosystems, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl provides novel rare cell technologies and solutions that offer clinical researchers with access to resolution in the study of cells and their molecular characterization. It specializes in liquid biopsy and single-cell technologies. The company’s product portfolio includes cellsearch systems; CellMag kits, tool, consumables; Deparray products; VRNXT technology system components and consumables and molecular kits among others. Menarini Silicon is headquartered in Huntingdon Valley, Pennsylvania, the US.

The key metrics of Menarini Silicon Biosystems related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Menarini Silicon Biosystems is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Menarini Silicon Biosystems.

For a detailed understanding of the performance of Menarini Silicon Biosystems, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.